本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mirum Pharmaceuticals, Inc.

94.48
+1.841.98%
成交量:19.17萬
成交額:1,802.09萬
市值:57.01億
市盈率:-201.01
高:94.97
開:92.56
低:90.57
收:92.64
52周最高:109.28
52周最低:36.88
股本:6,034.16萬
流通股本:3,998.57萬
量比:0.71
換手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-0.4700
每股收益(LYR):-0.4700
淨資產收益率:-8.65%
總資產收益率:-1.83%
市淨率:18.12
市盈率(LYR):-201.01

資料載入中...

2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

重要事件披露

Form 8-K - Current report
2026/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

重要事件披露

Form 8-K - Current report
2025/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

重要事件披露

Form 8-K - Current report
2025/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities